Genetic variant showing a positive interaction with B-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol and triglyceride levels in coronary artery disease patients
Genetic variant showing a positive interaction with B-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol and triglyceride levels in coronary artery disease patients